Sarah Garner

3.8k total citations · 1 hit paper
60 papers, 2.4k citations indexed

About

Sarah Garner is a scholar working on Economics and Econometrics, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Sarah Garner has authored 60 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Economics and Econometrics, 15 papers in General Health Professions and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Sarah Garner's work include Health Systems, Economic Evaluations, Quality of Life (19 papers), Pharmaceutical Economics and Policy (13 papers) and Healthcare cost, quality, practices (8 papers). Sarah Garner is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (19 papers), Pharmaceutical Economics and Policy (13 papers) and Healthcare cost, quality, practices (8 papers). Sarah Garner collaborates with scholars based in United Kingdom, United States and Canada. Sarah Garner's co-authors include Hywel C Williams, Robert P. Dellavalle, Peter Littlejohns, John Newton, C Popescu, E. Anne Eady, Mike Clarke, Axel Mühlbacher, Christin Juhnke and Cathy Bennett and has published in prestigious journals such as The Lancet, Development and The Lancet Oncology.

In The Last Decade

Sarah Garner

57 papers receiving 2.3k citations

Hit Papers

Acne vulgaris 2011 2026 2016 2021 2011 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Acne vulgaris
    2011 803 citations Sarah Garner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Garner United Kingdom 26 924 555 412 223 220 60 2.4k
Marc Alexander Radtke Germany 32 2.2k 2.3× 504 0.9× 304 0.7× 158 0.7× 106 0.5× 97 3.6k
John S. Barbieri United States 24 1.1k 1.2× 91 0.2× 145 0.4× 181 0.8× 151 0.7× 159 1.9k
Simon Francis Thomsen Denmark 46 2.8k 3.0× 111 0.2× 335 0.8× 224 1.0× 404 1.8× 351 7.4k
Marius Rademaker New Zealand 32 1.5k 1.7× 67 0.1× 92 0.2× 282 1.3× 200 0.9× 164 3.2k
Aaron M. Drucker Canada 33 2.7k 3.0× 57 0.1× 81 0.2× 95 0.4× 158 0.7× 138 3.9k
Runsheng Wang United States 19 97 0.1× 166 0.3× 111 0.3× 297 1.3× 632 2.9× 42 3.9k
Åke Svensson Sweden 37 3.6k 3.8× 93 0.2× 82 0.2× 63 0.3× 161 0.7× 148 4.8k
Guogang Xu China 24 98 0.1× 161 0.3× 111 0.3× 47 0.2× 838 3.8× 66 4.2k
Michael A. Silverman United States 28 96 0.1× 79 0.1× 156 0.4× 63 0.3× 780 3.5× 80 2.7k

Countries citing papers authored by Sarah Garner

Since Specialization
Citations

This map shows the geographic impact of Sarah Garner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Garner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Garner more than expected).

Fields of papers citing papers by Sarah Garner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Garner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Garner. The network helps show where Sarah Garner may publish in the future.

Co-authorship network of co-authors of Sarah Garner

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Garner. A scholar is included among the top collaborators of Sarah Garner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Garner. Sarah Garner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garner, Sarah, et al.. (2024). Ketogenic diet has a positive association with mental and emotional well-being in the general population. Nutrition. 124. 112420–112420. 19 indexed citations
2.
Garner, Sarah, Emma Barkus, & Ann-Katrin Kraeuter. (2024). Positive and negative schizotypy personality traits are lower in individuals on ketogenic diet in a non-clinical sample. Schizophrenia Research. 270. 423–432. 4 indexed citations
3.
Rejón-Parrilla, Juan Carlos, et al.. (2023). Pricing and reimbursement mechanisms for advanced therapy medicinal products in 20 countries. Frontiers in Pharmacology. 14. 1199500–1199500. 8 indexed citations
4.
Vihta, Karina-Doris, et al.. (2023). Cycle Threshold Values as Indication of Increasing SARS-CoV-2 New Variants, England, 2020–2022. Emerging infectious diseases. 29(10). 2024–2031. 1 indexed citations
5.
Curtiss, Sarah L., et al.. (2023). Sex.Ed.Agram: Co-created Inclusive Sex Education on Instagram. Sexuality and Disability. 41(3). 483–502. 4 indexed citations
6.
Brinkman, David J., Milan C. Richir, Paraskevi Papaioannidou, et al.. (2021). European List of Essential Medicines for Medical Education: a protocol for a modified Delphi study. BMJ Open. 11(5). e045635–e045635. 6 indexed citations
7.
Vogler, Sabine, et al.. (2021). European collaborations on medicine and vaccine procurement. Bulletin of the World Health Organization. 99(10). 715–721. 21 indexed citations
8.
Garner, Sarah, et al.. (2020). Medicines with one seller and many buyers: strategies to increase the power of the payer. BMJ. 369. m1705–m1705. 13 indexed citations
9.
10.
Folter, Joost de, Mark Trusheim, Páll Jónsson, & Sarah Garner. (2018). DECISION-COMPONENTS OF NICE'S TECHNOLOGY APPRAISALS ASSESSMENT FRAMEWORK. International Journal of Technology Assessment in Health Care. 34(2). 163–171. 8 indexed citations
11.
Sharma, Tarang, et al.. (2015). EVIDENCE INFORMED DECISION MAKING: THE USE OF “COLLOQUIAL EVIDENCE” AT NICE. International Journal of Technology Assessment in Health Care. 31(3). 138–146. 26 indexed citations
12.
Parkinson, Bonny, Catherine Sermet, Fiona Clement, et al.. (2015). Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. PharmacoEconomics. 33(9). 905–924. 66 indexed citations
13.
14.
Partridge, Sally R., Andrew N. Ginn, Agnieszka M. Wiklendt, et al.. (2014). Emergence of blaKPC carbapenemase genes in Australia. International Journal of Antimicrobial Agents. 45(2). 130–136. 46 indexed citations
15.
Garner, Sarah & Peter Littlejohns. (2011). Disinvestment from low value clinical interventions: NICEly done?. BMJ. 343(jul27 2). d4519–d4519. 118 indexed citations
16.
Littlejohns, Peter, et al.. (2009). 10 years of NICE: still growing and still controversial. The Lancet Oncology. 10(4). 417–424. 26 indexed citations
17.
Dhalla, Irfan A., Sarah Garner, Kalipso Chalkidou, & Peter Littlejohns. (2009). Perspectives on the National Institute for Health and Clinical Excellence's recommendations to use health technologies only in research. International Journal of Technology Assessment in Health Care. 25(3). 272–280. 24 indexed citations
18.
Garner, Sarah, E. Anne Eady, C Popescu, Richard Newton, & A. Li Wan Po. (2003). Minocycline for acne vulgaris: efficacy and safety. Cochrane Database of Systematic Reviews. CD002086–CD002086. 40 indexed citations
19.
Garner, Sarah, Dogan Fidan, Maria Judd, et al.. (2002). Celecoxib for rheumatoid arthritis. Cochrane Database of Systematic Reviews. CD003831–CD003831. 39 indexed citations
20.
Kung, Mei‐Ping, et al.. (1994). Characterization of binding sites for [125I]R(+)trans-7-OH-PIPAT in rat brain. Naunyn-Schmiedeberg s Archives of Pharmacology. 350(6). 611–7. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc Alexander Radtke Breakdown of academic impact, for papers by John S. Barbieri Breakdown of academic impact, for papers by Simon Francis Thomsen Breakdown of academic impact, for papers by Marius Rademaker Breakdown of academic impact, for papers by Aaron M. Drucker Breakdown of academic impact, for papers by Runsheng Wang Breakdown of academic impact, for papers by Åke Svensson Breakdown of academic impact, for papers by Guogang Xu Breakdown of academic impact, for papers by Michael A. Silverman
Rankless by CCL
2026